Clinical trials · Utah
Clinical Stage IV Cutaneous Melanoma AJCC v8 clinical trials in Utah
We’re tracking 3 recruiting clinical stage iv cutaneous melanoma ajcc v8 studies with a site in Utah — including Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies in Utah
- NCT05136196RecruitingPhase 2
Cabozantinib plus nivolumab for advanced melanoma or head-neck cancer
This trial tests whether combining two immunotherapy medicines—cabozantinib and nivolumab—can shrink advanced melanoma or certain head-and-neck squamous cell cancers. It is mainly for people whose cancer has grown after prior PD-1 treatment.
Salt Lake City, UtahAges 18 years+ - NCT04511013RecruitingPhase 2
Trial for BRAF-mutant melanoma spread to the brain
This Phase 2 study tests whether a 3-drug plan (encorafenib + binimetinib + nivolumab) works better than ipilimumab + nivolumab for melanoma that has spread to the brain. If you qualify, you’ll get either treatment and have frequent brain scans to track how well it controls the tumors.
Salt Lake City, UtahAges 18 years+ - NCT05896839RecruitingPhase 1/Phase 2
Immunotherapy with prednisone and sirolimus for transplant skin cancer
This early-phase study tests whether adding immunotherapy (nivolumab and ipilimumab) to prednisone and sirolimus can control advanced skin cancers in people with kidney transplants. It aims to see how well the treatment works and how safe it is for transplant recipients.
Salt Lake City, UtahAges 18 years+
Clinical Stage IV Cutaneous Melanoma AJCC v8 trials by city in Utah
Where these studies are running in Utah
Institutions with a site for the recruiting clinical stage iv cutaneous melanoma ajcc v8 studies listed above.
- Huntsman Cancer Institute/University of Utah · 3 studies
What taking part in a clinical stage iv cutaneous melanoma ajcc v8 study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Clinical Stage IV Cutaneous Melanoma AJCC v8 trials in other states
Common questions
- Are there clinical stage iv cutaneous melanoma ajcc v8 clinical trials in Utah?
- Yes. We're currently tracking 3 recruiting clinical stage iv cutaneous melanoma ajcc v8 studies with a site in Utah, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a clinical stage iv cutaneous melanoma ajcc v8 study in Utah?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Utah to take part?
- Not necessarily. These studies have a site in Utah, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a clinical stage iv cutaneous melanoma ajcc v8 trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New clinical stage iv cutaneous melanoma ajcc v8 studies open in Utah regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.